Presence of mutations associated with ganciclovir resistance in cytomegalovirus UL97 gene;Búsqueda de mutaciones en el gen UL 97 asociadas a resistencia a ganciclovir en citomegalovirus obtenidos desde muestras biológicas de pacientes chilenos

Revista Medica de Chile

Volumn 138, Issue 4, 2010, Pages 421-427

  Oyarzún, María Angélica ^a   Bustos, Patricia ^b   González, Marcela ^a   Domínguez, María Isabel ^c   Aguayo, Francisco ^b   Nervi, Bruno ^d   Ferres, Marcela ^a,b  

^a Campus Norte Universidad de Chile   (Chile)

^b PONTIFICIA UNIVERSIDAD CATÓLICA DE CHILE   (Chile)

^c Departamento de Medicina Interna   (Chile)

^d Departamento de Oncología y Hematología   (Chile)

Author keywords

Anti viral drug resistance; Cytomegalovirus; Ganciclovir

Indexed keywords

ANTIVIRUS AGENT; GANCICLOVIR; GANCICLOVIR KINASE; PHOSPHOTRANSFERASE;

ADOLESCENT; ADULT; ANTIVIRAL RESISTANCE; ARTICLE; CHILD; CHILE; CYTOMEGALOVIRUS; DRUG EFFECT; GENETICS; HUMAN; IMMUNOCOMPROMISED PATIENT; MIDDLE AGED; MUTATION; NUCLEOTIDE SEQUENCE; PRESCHOOL CHILD; VIRUS GENOME;

ADOLESCENT; ADULT; ANTIVIRAL AGENTS; BASE SEQUENCE; CHILD; CHILD, PRESCHOOL; CHILE; CYTOMEGALOVIRUS; DRUG RESISTANCE, VIRAL; GANCICLOVIR; GENOME, VIRAL; HUMANS; IMMUNOCOMPROMISED HOST; MIDDLE AGED; MUTATION; PHOSPHOTRANSFERASES (ALCOHOL GROUP ACCEPTOR); YOUNG ADULT;

EID: 77954422871     PISSN: 00349887     EISSN: 07176163     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. Erice A. Resistance of human cytomegolvirus to antiviral drug. Clin Microbiol Rev 1999; 12: 286-97.
2. Ljungman P, Griffiths P, Paya C. Definitions of Cytomegalovirus Infection and Disease in Transplant Recipients. Clin Infect Dis 2002; 34: 1094-97.
3. Crumpacker CS. Ganciclovir. N Engl J Med 1996; 335: 721-9.
4. Avery RK. Management of late, recurrent, and resistant cytomegalovirus in transplant patients. Transplantation Reviews 2007; 21: 65-76.
5. Boeckh M, Bowden RA, Goodrich JM, Pettinger M, Meyers JD. Cytomegalovirus antigen detection in peripheral blood leukocytes after allogeneic marrow transplantation. Blood 1992; 80: 1358-64.
6. Drew L. Laboratory diagnosis of cytomegalovirus infection and disease in inmocompromised patientes. Curr Opin Infect Dis 2007; 20: 408-11.
7. Jabs DA, Enger C, Dunn JP, Forman M. Cytomegalovirus retinitis and viral resistance: ganciclovir resistance. CMV Retinitis and Viral Resistance Study Group. J Infect Dis 1998; 177: 770-3.
8. Limaye AP, Corey L, Koelle D, Davis C, Boeckh M. Emergence of ganciclovir-resistant cytomegalovirus disease among recipients of solid-organ transplants. Lancet 2000; 356: 645-9.
9. Limaye AP. Ganciclovir-Resistant Cytomegalovirus in Organ transplant Recipients. Clin Infect Dis 2002; 35: 866-72.
10. Slavin MA, Bindra RR, Gleaves CA, Pettinger MB, Bowden RA. Ganciclovir sensitivity of cytomegalovirus at diagnosis and during treatment of cytomegalovirus pneumonia in marrow transplant recipients. Antimicrob Agents Chemother 1993; 37: 1360-63.
11. Reusser P, Cordonnier C, Einsele H, Engelhard D, Link D, Locasciulli A, et al. European survey of herpesvirus resistance to antiviral drugs in bone marrow transplant recipients. Bone Marrow Transplant 1996; 17: 813-17.
12. Marfori JE, Exner MM, Marousek GI, Chou S, Drew WL. Development of new cytomegalovirus UL 97 and DNA polymerase mutations conferring drug resistance after valganciclovir therapy in allogenic stem cell recipients. J Clin Virol 2007; 38: 120-25.
13. Lurain NS, Spafford LE, Thompson KD. Mutation in the UL97 open reading frame of human cytomegalovirus strain resistant to ganciclovir. J Virol 1994; 68: 4427-31.
14. Lurain NS, Weinberg A, Crumpacker CS, Chou S. Sequencing of cytomegalovirus UL97 gene for genotypic antiviral resistance testing. Antimicrob Agents Chemother 2001; 45: 2775-80.
15. Yeo A, Peng Chan K, Kumarasinghe G, Kim Yap H. Rapid detection of codon 460 mutations in the UL97 gene of ganciclovir - resitant cytomegalovirus clinical isolates by PCR using molecular beacons. Molecular and Cellular Probes 2005; 19: 389-93.
16. Göhring K, Mikeler E, Jahn G, Hamprecht K. Rapid simultaneous detection by real-time PCR of cytomegalovirus UL97 mutations in codons 460 and 520 conferring ganciclovir resistance. J Clin Microbiol 2006; 44: 4541-4.
17. Gilbert C, Bestman-Smith J, Boivin G. Resistance of herpesviruses to antiviral drugs: clinical impacts and molecular mechanisms. Drug Resistance Updates 2002; 5: 88-114.
18. Castor J, Cook L, Corey L, Jerome K. Rapid detection directly from patient serum samples of human cytomegalovirus UL97 mutations conferring ganciclovir resistance. J Clin Microbiol 2007; 45: 2681-3.
19. Avery RK. Update in management of ganciclovir-resistant cytomegalovirus infection. Current Opinion in infectious diseases 2008; 21: 433-37.
20. Chou S. Cytomegalovirus UL97 mutations in the era of ganciclovir and maribavir. Rev Med Virol 2008; 18: 233-46.
21. Cicin-Sain L, Podlech J, Messerle M, Reddehase M, Koszinowski U. Frequent coinfection of cells explains functional in vivo complementation between cytomegalovirus variants in the multiply infected host. J Virol 2005; 9492-502.